Merind Limited Unlisted Shares

Merind Limited Unlisted Shares

main img

Market Cap (cr): ₹78.7 Cr Book Value: ₹50.8
Lot Size: 100 shares 52 Week High: ₹350
52 Week Low: ₹163 EPS: ₹15.6
Demat Account: PB: 4.25
Face Value: ₹10 Debt To Equity: 0.06
No Of Shares: 36,42,000 Url:
Overview :

Company Overview

Merind Limited, founded in 1958, is a legacy pharmaceutical and APIs (Active Pharmaceutical Ingredients) company headquartered in Mumbai. Now a privately held entity after delisting in 2005 (via amalgamation), Merind has a strong track record in key pharma sectors, consistently posting robust profit margins and maintaining a stable balance sheet. The company stands out for its experience in formulation and generics manufacturing, lean operations, and focus on capital stewardship—making it a unique long-term value play in India’s pharma ecosystem.

Merind operated in Indian pharmaceuticals during a period of substantial industry transformation. The sector's history from the 1970s onward was shaped by:

  • The Patents Act 1970, which permitted process patents only — enabling Indian companies to reverse-engineer drugs and build a generics industry
  • Drug price control under the DPCO, which constrained margins on essential medicines
  • Consolidation from the 1990s onward, as larger Indian and multinational companies acquired smaller manufacturers to gain products, plants and market access
  • The 2005 product patent regime, which fundamentally reshaped the industry

Many mid-size Indian pharmaceutical companies of that era were acquired and absorbed — which is why entity verification is essential when dealing with shares from that period.

FAQs

What is the current status of Merind Limited shares?

This must be verified before transacting. Merind has a complex corporate history involving ownership changes and restructuring. Call Arms Securities at +91-8882245112 and we will confirm the exact entity, its CIN, whether it is active, merged or dissolved, and whether shares are genuinely available and transferable.

What was Merind Limited?

Merind was an Indian pharmaceutical company, historically associated with the Tata group's pharmaceutical interests and subsequently with Wockhardt. Its exact current corporate position requires verification.

I hold Merind share certificates. What should I do?

Call +91-8882245112. Arms Securities specialises in physical certificates, merged entities, dormant companies and transmission cases. We will verify what your holding represents today, authenticate the certificates, handle transmission if the shares were inherited, assist with dematerialisation where possible, and tell you honestly whether a realisable value exists.

Can I still buy Merind shares?

Only if the entity is active and shares are genuinely transferable — which must be verified first. Call Arms Securities at +91-8882245112 before committing any funds. We would rather spend ten minutes checking than let you buy something that no longer exists in the form you expect.

What happens to shareholders when a company is merged?

It depends on the scheme. You may receive shares in the acquirer at a determined swap ratio, receive cash consideration with your shares extinguished, hold shares in a continuing shell entity, or — if the company was struck off — hold shares with no value at all. Only the actual scheme documents determine which applies.

If my Merind shares have no value, is there anything I can do?

Possibly. Realising a capital loss can be set off against other capital gains under Indian tax law, which has genuine monetary value. Arms Securities can advise on how to formally realise the position, and you should consult a Chartered Accountant on the tax treatment.

 

+91-8882245112contact@armssecurities.com

Physical share assistance → | Delisted shares guide →

Board of Directors

NameDesignation
Huzaifa Habil KhorakiwalaDirector
Zahabiya Habil KhorakiwalaDirector
Stephen Sabbas D’souzaDirector

 

Company Incorporation Details

AttributeDetails
Company NameMerind Limited
CINU24239MH1958PLC011204
Date of Incorporation4 November 1958
Registered OfficeReadymoney Terrace, 2nd Floor, Room 5, 167 Dr. Annie Besant Road, Mumbai – 400018, Maharashtra
Face Value₹10
ISININE215A01016
Lot Size100 shares
Demat AccountMandatory

Shareholding Pattern (FY2025)

Category% Holding
Promoter (Dartmour Holdings Pvt Ltd)96.06
Public/Other Shareholders3.94

Sector

  • Industry: Pharmaceuticals
  • Segment: APIs, Formulations, Heritage Generics

Why Choose Arms Securities?

Trade Merind Limited unlisted shares with confidence—benefiting from transparent pricing, regulatory safety, and true end-to-end support powered by Arms Securities.

Net Sales (in cr.)
Total Income (in cr.)
Operating Profit (in cr.)

Net Profit (in cr.)
Shareholder Funds (in cr.)
Total Assets (in cr.)

News

Financial Docs

Date/PeriodDownload
Annual Report 2021-2022
Annual Report 2022-2023
Annual Report 2023-2024

Frequently Ask Question

Have Your Any Question?

Connect with Arms Securities for live quotes, then use a demat account for SEBI-compliant, fully documented settlement.

Submit your Delivery Instruction Slip (DIS) for demat-to-demat transfer; Arms Securities handles the process.

For most pre-owned/secondary trades, no lock-in applies; new regulatory blocks may require up to 6 months (as per SEBI).

Exclusively through SEBI-recognized brokers such as Arms Securities for legal, transparent deals.

A DIS allows transfer of shares securely from seller’s to buyer’s demat after both parties’ approval.

Yes, if all trades are routed via compliant intermediaries and settled through recognized processes.

Short Term: slab rate if held ≤24 months. Long Term: 20% with indexation. Dividends are taxed at recipient’s slab.

Yes—SEBI regulates the process, requiring KYC, contract notes, and demat-based settlement.

From promoters, strategic holders, or prior investors who hold in demat (with full compliance diligence).

Subscribe for Arms Securities’ daily updates or check company filings for news.